CANY
NGVT icon

Caxton Associates (New York)’s Ingevity NGVT Stock Holding History

Caxton Associates (New York)’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,598
Closed -$378K – 491
2019
Q2 		$378K Buy
+3,598
New +$362K 0.05% 242

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Caxton Associates (New York)'s NGVT Position: Q3 2019 in Review

Caxton Associates (New York) sold out of Ingevity (NGVT) in Q3 2019, closing a stake of 3,598 shares — an estimated $378K sold.

Caxton Associates (New York) first reported a position in NGVT in Q2 2019 and held it in 1 quarter. The position peaked at $378K in Q2 2019. 335 funds tracked by Wall St. Rank hold NGVT as of Q3 2019.

  • Caxton Associates (New York) reported no remaining Ingevity position as of Q3 2019 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,598 Ingevity shares in Q3 2019, an estimated $378K.
  • Caxton Associates (New York) first reported a position in Ingevity in Q2 2019 and held it in 1 quarter.
  • Caxton Associates (New York)'s Ingevity position peaked at $378K in Q2 2019.
  • 335 funds tracked by Wall St. Rank held Ingevity as of Q3 2019.

Based on Caxton Associates (New York)'s 13F filing for Q3 2019, filed 14 Nov 2019.